Can external and subjective information ever be used to reduce the size of randomised controlled trials?

Contemporary Clinical Trials

Volumn 29, Issue 2, 2008, Pages 211-219

  Tan, Say Beng ^a,b,c   Wee, Joseph ^b,c   Wong, Hwee Bee ^a,c   Machin, David ^a,b,c  

^a Clinical Trials and Epidemiology Research Unit   (Singapore)

^b DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Bayesian; Design of randomised controlled trials; Nasopharyngeal carcinoma; Sample size

Indexed keywords

CISPLATIN; FLUOROURACIL;

ANALYSIS; ARTICLE; BAYES THEOREM; CASE STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MEDICAL INFORMATION; METHODOLOGY; NASOPHARYNX CARCINOMA; RANDOMIZED CONTROLLED TRIAL;

HUMANS; NASOPHARYNGEAL NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; SAMPLE SIZE;

EID: 39149121831     PISSN: 15517144     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cct.2007.07.009     Document Type: Article

References (19)

1. Tan S.B., Dear K.B.G., Bruzzi K., and Machin D. Strategy for randomised clinical trials in rare cancers. BMJ 327 (2003) 47-49
2. Sutton A.J., Cooper N.J., Jones D.R., Lambert P.C., Thompson J.R., and Abrams K.R. Evidence-based sample size calculations based upon updated meta-analyses. Statist Medd 26 (2007) 2379-2500
3. Spiegelhalter D.J., Myles P., Jones D.R., and Abrams K.R. An introduction to Bayesian methods in health technology assessment. BMJ 319 (1999) 508-512
4. Tan S.B., Chung Y.F.A., Tai B.C., Cheung Y.B., and Machin D. Elicitation of prior distributions for a Phase III randomized controlled trial of adjuvant therapy with surgery for hepatocellular carcinoma. Control Clin Trials 24 (2003) 110-121
5. Begg C., Cho M., Eastwood S., Horton R., Moher D., Olkin I., Pitkin R., Rennie D., Schulz K.F., Simel D., and Stroup D.F. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 276 (1996) 637-639
6. Wee J.T.S., Tan E.H., Tai B.C., et al. Randomized trial of radiotherapy versus concurrent chemo-radiotherapy followed by adjuvant chemotherapy in patients with AJCC/UICC (1997) Stage III and IV nasopharyngeal cancer of the endemic variety. J Clin Oncol 23 (2005) 6730-6738
7. Spiegelhalter D.J., Freeman L.S., and Parmar M.K.B. Bayesian approaches to randomised trials. J R Stat Soc Ser A Stat Soc 157 (1994) 357-416
8. Al-Sarraf M., LeBlanc M., Giri P.G., et al. Superiority of chemo-radiotherapy versus radiotherapy in patients with locally advanced nasopharyngeal cancer. Preliminary results of intergroup (0099) (SWOG 8892, RTOG 8817, ECOG 2388) randomised study (Abstract). Proc ASCO 15 (1996) 313
9. Al-Sarraf M., Pajak T.F., Cooper J.S., Mohiuddin M., Herskovic A., and Ager P.J. Chemo-radiotherapy in patients with locally advanced nasopharyngeal carcinoma: a radiation therapy oncology group study. J Clin Oncol 8 (1990) 1342-1351
10. Dimery I.W., Legha S.S., Peters L.J., Goepfert H., and Oswald M.J. Adjuvant chemotherapy for advanced nasopharyngeal carcinoma. Cancer 60 (1987) 943-949
11. Al-Sarraf M., LeBlanc M., Giri P.G.S., et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomised intergroup study 0099. J Clin Oncol 16 (1998) 1310-1317
12. Heng D.M.K., Wee J., Fong K.W., et al. Prognostic factors in 677 patients in Singapore with nondisseminated nasopharyngeal carcinoma. Cancer 86 (1999) 1912-1920
13. Tan E.H., Chua E.T., Wee J., et al. Concurrent chemoradiotherapy followed by adjuvant chemotherapy in Asian patients with nasopharyngeal carcinoma: toxicities and preliminary results. Int J Radiat Oncol Biol Phys 45 (1999) 597-601
14. Cooper J.S., Lee H., Torrey M., and Gochster H. Improved outcome secondary to concurrent chemoradiotherapy for advanced carcinoma of the nasopharynx: preliminary corroboration of the intergroup experience. Int J Radiat Oncol Biol Phys 47 (2000) 861-866
15. Chow E., Payne D., O'Sullivan B., et al. Radiotherapy alone in patients with advanced nasopharyngeal cancer: comparison with an intergroup study. Is combined modality treatment really necessary?. Radiother Oncol 63 (2002) 269-274
16. Chua D.T.T., Sham J.S.T., Au G.K.H., and Choy D. Concomitant chemoirradiation for stage III-IV nasopharyngeal carcinoma in Chinese patients: results of a matched cohort analysis. Int J Radiat Oncol Biol Phys 53 (2002) 334-343
17. Hillner B.E. Trends in clinical trials reports in common cancers between 1989 and 2000. J Clin Oncol 21 (2003) 1850-1858
18. Gotay C.C. Increasing trial generalizability. J Clin Oncol 24 (2006) 846-847
19. Spiegelhalter D.J., Abrams K.R., and Myles J.P. Bayesian approaches to clinical trials and health-care evaluation (2004), Wiley, Chichester